Pharmacist

Valbiotis publishes its annual accounts 2023

Retrieved on: 
Venerdì, Maggio 3, 2024
FDA, Sales management, Partnership, Hypercholesterolemia, Sleep, INSIGHT, Prevalence, Insulin resistance, Inflammation, DSM-IV codes, Food, Communication, Cholecalciferol, Executive Committee, Pharmacist, Pharmacy, Volunteering, INAF, Phase, Practitioner, Incretin, EFSA, Safety, Omega-3 fatty acid, Agonal respiration, Human, LDL, Marketing, Prediabetes, NAFLD, Endocrine gland, NDI, Food and Drug Administration, Meal, Commercial, Dietary supplement, Blood pressure, Patient, Statutory auditor, Metabolism, Hypertension, Cardiovascular disease, Bank statement, Pharmaceutical industry

Sébastien PELTIER, Chairman of the Executive Committee and Co-Founder of Valbiotis, comments: ‘’2023 was one of Valbiotis' most productive years since the Company was founded just ten years ago.

Key Points: 
  • Sébastien PELTIER, Chairman of the Executive Committee and Co-Founder of Valbiotis, comments: ‘’2023 was one of Valbiotis' most productive years since the Company was founded just ten years ago.
  • By accelerating its structuring, Valbiotis also laid the foundations for 2024, which promises to be particularly fruitful.
  • The Company's 2023 financial statements, drawn up in accordance with IFRS, were approved by the Board of Directors on April 23, 2024.
  • They have been audited by the Statutory Auditor and are available on the Valbiotis website: www.valbiotis.com/en (investors section).

Infectious Disease Connect Expands Telemedicine Services

Retrieved on: 
Martedì, Aprile 16, 2024
Telehealth, Hospital, OPAT, Infection, Entrepreneurship, Nursing, Patient, Physician, Health, ID, Pharmacist

PITTSBURGH, April 16, 2024 (GLOBE NEWSWIRE) -- Infectious Disease Connect (ID Connect), a leading infectious diseases telemedicine and software solutions company, has expanded its services to meet growing demand.

Key Points: 
  • PITTSBURGH, April 16, 2024 (GLOBE NEWSWIRE) -- Infectious Disease Connect (ID Connect), a leading infectious diseases telemedicine and software solutions company, has expanded its services to meet growing demand.
  • The company now offers two cutting-edge service lines — pediatric infectious diseases telemedicine (tele-ID) and tele-Outpatient Parenteral Antimicrobial Therapy (tele-OPAT).
  • Addressing the problem of access to pediatric infectious diseases care, ID Connect's pediatric tele-ID service provides right-sized, top-quality pediatric ID care to hospitals and health systems via telemedicine.
  • Without our services, one hospital would have resorted to transferring approximately 30% of their pediatric infectious diseases cases.

FountainRx Selects Inovalon’s ScriptMed® Software To Enhance Patient Care and Scale Specialty and Infusion Pharmacy Services

Retrieved on: 
Martedì, Aprile 16, 2024
Inovalon, Health, Data, Patient, Pharmacist, Infusion, Growth

BOWIE, Md., April 16, 2024 (GLOBE NEWSWIRE) -- Inovalon , a leading provider of cloud-based software solutions empowering data-driven healthcare, today announced that FountainRx Specialty Pharmacy , a leading independent national provider of specialty pharmacy and infusion services, has selected Inovalon's ScriptMed pharmacy management software to support its ongoing growth and expansion.

Key Points: 
  • BOWIE, Md., April 16, 2024 (GLOBE NEWSWIRE) -- Inovalon , a leading provider of cloud-based software solutions empowering data-driven healthcare, today announced that FountainRx Specialty Pharmacy , a leading independent national provider of specialty pharmacy and infusion services, has selected Inovalon's ScriptMed pharmacy management software to support its ongoing growth and expansion.
  • As FountainRx continues to expand its national presence and capabilities, the accredited provider of specialty pharmacy, infusion, and compounding services needed a cloud-based platform to scale and drive improved operational efficiencies, support strategic initiatives, and provide greater value to pharmaceutical partners and payers.
  • Leveraging both ScriptMed's Specialty and Infusion solutions, FountainRx will automate manual workflows to equip its pharmacists with actionable, data-driven insights to manage patient care, optimize medication management, enhance access to life-saving therapies, and maintain compliance across its specialty and infusion pharmacy network.
  • ScriptMed will help them equip pharmacists with data to support a more personalized approach to treatment and improve patient access to specialty therapies nationwide."

The ADHD Expert Consortium Hosts Third Annual Meeting

Retrieved on: 
Giovedì, Maggio 2, 2024
Public Policy, Government, Mental Health, State, Local, Health, Neurology, Health Technology, General Health, Policy, Insurance, MD, ADHD, Depression, Consortium, Pediatrics, Patient, Diagnosis, Patient satisfaction, Anxiety, Pharmacist, Call to Action

The ADHD Expert Consortium, a diverse group of professionals advocating for improved ADHD care, held its third annual meeting in Houston, Texas.

Key Points: 
  • The ADHD Expert Consortium, a diverse group of professionals advocating for improved ADHD care, held its third annual meeting in Houston, Texas.
  • During this year’s in-person meeting, the group objective was to identify discrepancies between the guidelines outlined in medical necessity policies and their day-to-day work with patients.
  • “Despite increased awareness, understanding, and technological advancements surrounding ADHD, the diagnostic process has remained unchanged for decades.
  • To support these efforts and bring a wealth of expertise in the policy and payor space, the ADHD Expert Consortium added Dori Martini as its newest member.

DoseMe Enables Precision Dosing at Independence Health System

Retrieved on: 
Giovedì, Maggio 2, 2024
Biotechnology, Technology, Professional Services, Health, Pharmaceutical, Health Technology, Medical Devices, Data Analytics, Software, Hospitals, Genetics, Pharmacogenomics, Palliative care, Hospital, Cardiology, Elective surgery, Partnership, BCPS, Patient, Record, Doctor of Pharmacy, Physician, AUC, Excela Health, Pharmacist, Pharmaceutical industry

DoseMe , a leading provider of model-informed precision dosing (MIPD) software, has announced its collaboration with Excela Health, now part of Independence Health System .

Key Points: 
  • DoseMe , a leading provider of model-informed precision dosing (MIPD) software, has announced its collaboration with Excela Health, now part of Independence Health System .
  • This alliance will advance therapeutic drug monitoring and optimize pharmacogenetics integration into pharmacokinetic/pharmacodynamic (PK/PD) models as part of IHS’s precision dosing strategy and initiatives.
  • With five hospitals, nearly 1,000 healthcare providers and more than 7,000 employees, Independence Health System serves a ten county region and is the largest employer in Butler and Westmoreland counties.
  • For more information on precision dosing models offered by DoseMe, visit https://doseme-rx.com/why-dosemerx/drug-packages

Surescripts Launches Third Season of Its Award-Winning Podcast There’s A Better Way

Retrieved on: 
Mercoledì, Maggio 1, 2024
Public Policy, Government, Practice Management, Pharmaceutical, Managed Care, General Health, Health, Healthcare Reform, Health Technology, FDA, Professional, Organization, Mayo Clinic, HHS, Human services, Marketing, EHR, Health care, Customer experience, Patient safety, Patient, Surescripts, Gold, American Telemedicine Association, MPP, Season, Better Way, EHNAC, Pharmacist, Management

Surescripts®, the nation’s leading health information network, launched the third season of its award-winning podcast, There’s a Better Way: Smart Talk on Healthcare and Technology.

Key Points: 
  • Surescripts®, the nation’s leading health information network, launched the third season of its award-winning podcast, There’s a Better Way: Smart Talk on Healthcare and Technology.
  • Listen to There’s a Better Way: Season 3 trailer .
  • Surescripts introduced There’s a Better Way: Smart Talk on Healthcare and Technology in July 2022.
  • Both season one and season two were recognized by the Association of Marketing and Communication Professionals, receiving the 2022 Gold MarCom Award and the 2023 Platinum MarCom Award, respectively.

Ventegra Announces the Successful Implementation of the New Ventegra Specialty Inclusion (VSI) Program

Retrieved on: 
Mercoledì, Maggio 1, 2024
Technology, Consulting, Professional Services, Health Insurance, Software, Practice Management, Managed Care, Pharmaceutical, Health, Data Management, Pharmacy, Probability, Safety, Explanation, Plasma protein binding, MBM, Pharming, MBA, Pharmacist, VSI

The VSI program underscores Ventegra’s clinical infrastructure and heritage as a company managed and operated predominantly by healthcare professionals, pharmacists, and certified pharmacy technicians.

Key Points: 
  • The VSI program underscores Ventegra’s clinical infrastructure and heritage as a company managed and operated predominantly by healthcare professionals, pharmacists, and certified pharmacy technicians.
  • Mark Shinmoto, Pharm.D., Chief Pharmacy Officer, says, “The Ventegra Specialty Inclusion (VSI) program’s capability is a vital and important new tool in Ventegra’s ability to appropriately manage the utilization of the plethora of drugs being brought to market.
  • Robert T. Taketomo, Pharm.D., MBA, President/CEO, explains, “The Ventegra Specialty Inclusion program reflects the clinical focus of Ventegra and our deep commitment to member care and managed care principles.
  • Unlike most traditional pharmacy benefit managers, Ventegra does not have any fiduciary commitment to shareholders and exists to serve and benefit its community.

BioTek reMEDys Celebrates the Work of Healthcare Professionals During Patient Experience Week

Retrieved on: 
Mercoledì, Maggio 1, 2024
Nursing, Health, Hospitals, Practice Management, Managed Care, General Health, Pharmaceutical, Organization, Pharmacist, Patient, Communication, BioTek, Hope, Hospital, Physician

Inspired by members of the healthcare community who interface directly with patients, Patient Experience Week, or “PX Week,” provides a focused time for organizations to celebrate accomplishments, re-energize efforts and honor the people who routinely have a positive effect on patient well-being.

Key Points: 
  • Inspired by members of the healthcare community who interface directly with patients, Patient Experience Week, or “PX Week,” provides a focused time for organizations to celebrate accomplishments, re-energize efforts and honor the people who routinely have a positive effect on patient well-being.
  • From nurses and physicians to support staff, pharmacists and executive professionals, to patients, families and communities served, the hope is to bring together healthcare organizations across the globe to observe PX Week.
  • BioTek reMEDys is a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases.
  • Through supply chain management, innovative technology and trained specialty pharmacists, BioTek reMEDys is able to deliver superior service at a lower cost.

Baxter Reports First-Quarter 2024 Results

Retrieved on: 
Giovedì, Maggio 2, 2024
Medical Supplies, Medical Devices, Health, Pharmaceutical, Optical, Biotechnology, Sale, FDA, Baxter, Pharmacist, Sodium chloride, Food, Growth, LVP, SYR, Novum, Baxter International, Nursing, Patient, EPS, CDT, BPS, GAAP, Food and Drug Administration, Vasopressin

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2024.

Key Points: 
  • Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2024.
  • Regardless of the selected path, Baxter currently expects the separation of its Kidney Care business to take place in the second half of 2024.
  • For full-year 2024: Baxter now expects sales growth of approximately 2% on a reported basis and 2% to 3% on a constant currency basis.
  • A webcast of Baxter’s first-quarter 2024 conference call for investors can be accessed live from a link in the Investor Relations section of the company’s website at www.baxter.com beginning at 7:30 a.m. CDT on May 2, 2024.

Doceree Elevates Healthcare Affordability Technology with Co-Pay Spark Launch at Asembia 2024

Retrieved on: 
Martedì, Aprile 30, 2024
Health, HCP, Health care, Medicine, Patient, Marketing, Pharmacist, Health insurance

PARSIPPANY, N.J., April 30, 2024 /PRNewswire/ -- Doceree, the leading global healthcare marketing platform building unprecedented programmatic solutions for HCP marketing, today announced the launch of Co-Pay Spark at the Asembia 2024 conference in Las Vegas– a ground-breaking solution designed to enhance patient affordability and medication adherence by reaching the most influential stakeholder in Healthcare – The Healthcare Professional, who lacks awareness of Patient affordability programs.

Key Points: 
  • PARSIPPANY, N.J., April 30, 2024 /PRNewswire/ -- Doceree, the leading global healthcare marketing platform building unprecedented programmatic solutions for HCP marketing, today announced the launch of Co-Pay Spark at the Asembia 2024 conference in Las Vegas– a ground-breaking solution designed to enhance patient affordability and medication adherence by reaching the most influential stakeholder in Healthcare – The Healthcare Professional, who lacks awareness of Patient affordability programs.
  • "The launch of Co-Pay Spark marks a significant milestone in our mission to make healthcare more accessible and affordable for patients," said Harshit Jain MD, Founder & Global CEO, Doceree.
  • "Our integrated, platform-agnostic technology connects HCPs to treatment-specific and patient-personalized affordability solutions, not only benefitting patients but also empowering healthcare providers to enhance awareness and utilization of patient affordability programs."
  • Key features and benefits of Co-Pay Spark include:
    Reduced drug costs for patients through manufacturer coupons, e-vouchers, and assistance programs
    Doceree invites attendees of Asembia 2024 to visit their booth to learn more about Co-Pay Spark and explore how it can transform patient affordability in healthcare.